Clinical Trial

Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a randomized, double-blind, active drug- and placebo-controlled, dose-escalation clinical study conducted in patients scheduled to undergo abdominal surgery. It aims to evaluate the tolerability, safety, pharmacokinetics, and efficacy of SYH9089 Injection for postoperative analgesia in these patients.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-16
Trial Details
NCT Number NCT07519109
Lead Sponsor CSPC Ouyi Pharmaceutical Co., Ltd.
Conditions Postoperative Pain
Enrollment 60 participants
Start Date 2026-03-30
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-15